Predicting Local Recurrence in T3 Laryngeal Squamous Cell Carcinoma: An Analysis of Tumor Volume and Cartilage Invasion Prior to Radiotherapy
Cancer Medicine · 2026
DOI: 10.1002/cam4.71500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Rasmus Blomkvist und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, Intervention and Technology, CLINTEC, Otorhinolaryngology, Karolinska Institutet, and Karolinska University Hospital,…. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Neoplasm Recurrence, Local, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Radiumhemmets Forskningsfonder, Finska Läkaresällskapet, Stiftelsen Acta Oto-Laryngologica.
Abstract (Originalsprache)
Introduction
Patients with T3 laryngeal squamous cell carcinoma (LSCC) face a high risk of local recurrence after chemoradiotherapy (CRT) or radiotherapy (RT). This study examines whether tumor volume and inner cortex cartilage invasion (ICCI) predict local recurrence and survival. Materials and Methods Eighty‐six patients with T3 LSCC, treated with RT or CRT at the Karolinska University Hospital between 2005 and 2021, were included. Cox regression assessed the effect of associations between tumor volume and ICCI on local failure and 5‐year mortality, adjusting for treatment modality, tumor subsite, and vocal cord mobility.
Results
High tumor volume (> 5 mL) was associated with a threefold increase in local failure risk (HR 3.11, 95% CI 1.47–6.55). No significant associations were found between tumor volume and mortality, ICCI and local failure, or ICCI and mortality.
Conclusion
The results demonstrate that a larger tumor volume correlates with a reduced treatment response for patients with T3 LSCC treated with RT or CRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Science, Intervention and Technology, CLINTEC, Otorhinolaryngology, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden.
- Medical Unit, Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden.
- Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden.
- Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Otorhinolaryngology, Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
ORCID-Profile: Rasmus Blomkvist
Förderung
- Radiumhemmets Forskningsfonder
- Finska Läkaresällskapet
- Stiftelsen Acta Oto-Laryngologica
Zitieren
APA
Blomkvist, R., Palmgren, B., Gottlieb-Vedi, E., Jaraj, S. J., Mäkitie, A., Marklund, L., & Hammarstedt-Nordenvall, L. (2026). Predicting Local Recurrence in T3 Laryngeal Squamous Cell Carcinoma: An Analysis of Tumor Volume and Cartilage Invasion Prior to Radiotherapy. Cancer Medicine. https://doi.org/10.1002/cam4.71500
Vancouver
Blomkvist R, Palmgren B, Gottlieb-Vedi E, Jaraj SJ, Mäkitie A, Marklund L, et al. Predicting Local Recurrence in T3 Laryngeal Squamous Cell Carcinoma: An Analysis of Tumor Volume and Cartilage Invasion Prior to Radiotherapy. Cancer Medicine. 2026. doi:10.1002/cam4.71500
BibTeX
@article{Blomkvist2026,
author = {Blomkvist, Rasmus and Palmgren, Björn and Gottlieb-Vedi, Eivind and Jaraj, Sara Jonmarker and Mäkitie, Antti and Marklund, Linda and Hammarstedt-Nordenvall, Lalle},
title = {Predicting Local Recurrence in T3 Laryngeal Squamous Cell Carcinoma: An Analysis of Tumor Volume and Cartilage Invasion Prior to Radiotherapy},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71500}
}
EUVIMED